An enterococcal phage protein inhibits type IV restriction enzymes involved in antiphage defense

Nathan P Bullen1,2, Cydney N Johnson3, Shelby E Andersen3

  • 1Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4L8, Canada.

Nature Communications
|August 13, 2024
PubMed

Insights

Multidrug-resistant bacteria pose a growing threat. Researchers identified a new phage resistance mechanism in Enterococcus faecalis and discovered a phage inhibitor protein that overcomes this defense.

Area of Science:

  • Microbiology
  • Genetics
  • Molecular Biology

Background:

  • The rise of multidrug-resistant (MDR) bacterial infections, particularly MDR enterococci, is a critical global health concern.
  • Bacteriophage (phage) therapy offers a promising alternative to antibiotics, but bacterial resistance to phages is a significant challenge.
  • Understanding the genetic basis of phage resistance in MDR bacteria is crucial for developing effective phage therapies.

Purpose of the Study:

  • To identify genetic factors conferring phage resistance in *Enterococcus faecalis*.
  • To elucidate the mechanism by which phages overcome bacterial resistance.
  • To characterize a novel phage-inhibitor protein.

Main Methods:

  • Utilized CRISPR interference (CRISPRi) screening to identify phage resistance genes in *Enterococcus faecalis*.
  • Employed genetic and biochemical assays to characterize the function of a identified genetic locus and a restriction enzyme.
  • Investigated phage evolution and the mechanism of a phage-encoded inhibitor protein.

Main Results:

  • Identified a plasmid-borne locus in *Enterococcus faecalis* encoding a Type IV restriction enzyme (TIV-RE) that confers resistance to phage phi47.
  • Demonstrated that phage phi47 evolves to overcome TIV-RE restriction through mutations in a specific inhibitor protein.
  • Characterized the inhibitor, named type IV restriction inhibiting factor A (tifA), which binds and neutralizes diverse TIV-REs.

Conclusions:

  • Discovered a novel phage resistance mechanism mediated by a TIV-RE encoded on a mobilizable plasmid in *Enterococcus faecalis*.
  • Provided mechanistic insights into phage adaptation, highlighting the evolution of inhibitor proteins to overcome bacterial antiphage systems.
  • Advanced the understanding of phage-bacterial interactions in the context of multidrug-resistant pathogens.

Related Concept Videos

Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.0K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.5K
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
951
Restriction Enzymes01:11

Restriction Enzymes

Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
29.6K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K